Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Novartis to Revamp Marketing Structure in CNS Field, Shift from SOV
November 19, 2012
- Sawai Aims at Top Positions for New Products in Mediceo Utilizing Mediceo’s ARs: President Sawai
November 19, 2012
- E Keppra Grabs 20% Share of Domestic Anti-Epileptic Drug Market; Sales Growing Rapidly
November 19, 2012
- Medical System Network, Hanshin Dispensing Pharmacy to Set Up New Company for Drug Purchase Next April
November 16, 2012
- Nichi-Iko Aims to Initiate PI Study of Herceptin Biosimilar in FY2013: President Tamura
November 16, 2012
- 3 More Companies Temporarily Discontinue Marketing Generics Due to GMP Non-Compliance at South Korean Supplier
November 16, 2012
- Acquisitions Support Recovery in Leading Domestic Drug Makers’ Overseas Sales Ratio to 37%
November 15, 2012
- Shionogi, ViiV Obtain Favorable Results in 3rd PIII Clinical Trial for Dolutegravir
November 15, 2012
- Healthcare Sales Soar 4.4% with Expansion of Abilify in Japan: Otsuka HD
November 15, 2012
- OrphanPacific to Initiate New Business Model “Contract MAH for Overseas Pharma”
November 15, 2012
- Japan’s 25 Major Drug Makers Log Contrasting Domestic Biz Results on Varying New Product Performances
November 14, 2012
- RaQualia to Slim Down Its Organization Considering Spinning Off Non-Core Development Programs
November 14, 2012
- Towa: 1st Half Sales Up 16%, But Less-than Expected Benefits from Generic Name Prescriptions
November 14, 2012
- Gap between Oncology MRs and Doctors Should Be Closed: Mr Mitsuhashi of Merck Serono
November 13, 2012
- CMIC HD Forms Business Partnership with Japanese Subsidiary of Leading CSO in Europe
November 13, 2012
- Ethical Drug Sales Down 4.9% in September: Crecon Report
November 13, 2012
- Tsumura Postpones Targeted Launch for Kampo Medicine Under Development in US
November 13, 2012
- GeneDesign to Comprehensively Support Development of Nucleic Acid Medicines through New CMC Research Center: Mr Sato
November 13, 2012
- Sawai Makes Downward Revision in Full-Year Sales Forecast Despite Increases in Sales, Profits in 1st Half
November 12, 2012
- Alliance with Choseido to Increase Nihon Chouzai’s Generic Lineup to 470: President Mitsuhara
November 12, 2012
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…